# Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement

Source: https://welltoldgrants.com/grants/cdc-rfa-ps21-21030301supp23-integrated-viral-hepatitis-surveillance-and-prevention/  
Official notice: https://www.grants.gov/search-results-detail/345398

> Centers for Disease Control - NCHHSTP offered grants to the applicants described in the notice. It expected to make about 10 awards worth $250,000 in total. Applications closed on March 27, 2023.

| Field | Value |
|---|---|
| Opportunity number | CDC-RFA-PS21-21030301SUPP23 |
| Agency | Centers for Disease Control - NCHHSTP |
| Status | Forecast |
| Deadline | March 27, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 10 |
| Total funding | $250,000 |
| Cost sharing | not required |
| Assistance Listings | 93.270 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Currently funded recipients under CDC-RFA-PS21-2103 only.

## What the grant funds

The purpose of this NOFO is to announce the availability of supplemental funding for the organizations that were previously awarded funding under Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments (CDC-RFA-PS21-2103) (IVHSP). The primary goals of this Supplemental NOFO are to: 1) increase the early detection and interruption of hepatitis C outbreaks and transmission clusters; and 2) increase hepatitis B and hepatitis C diagnosis and treatment by providing routine testing and linkage to prevention and treatment in high-impact settings. This Supplemental NOFO includes two components and applicants may apply for one or both of the following components: Component 1: Integrating Genomic and Epidemiologic Surveillance for Outbreak Detection and Response. The purpose of this project is to work with health departments to develop an integrated epidemiological and molecular surveillance system for HCV infection to identify HCV transmission clusters and outbreaks for public health action. Component 2: Increasing Access to Hepatitis C and/or Hepatitis B Testing and Linkage to Care in High-Impact Settings. The purpose of this project is to work with partners to conduct testing and linkage to care for hepatitis B virus (HBV) and/or HCV infection in high-impact settings (e.g., syringe services programs or SSPs, substance use disorder treatment centers, correctional facilities, emergency departments, and sexually transmitted infections clinics).

## Questions people ask

### Is CDC-RFA-PS21-21030301SUPP23 still open?

No. It closed on March 27, 2023. A newer notice is forecast: CDC-RFA-PS-27-0011, expected deadline June 1, 2027.

### Who can apply for Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement?

Centers for Disease Control - NCHHSTP accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement?

Closed March 27, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $250,000 in total across about 10 awards.

### Who has won Viral Hepatitis Prevention and Control grants before?

The largest recipients over five fiscal years were National Alliance of State & Territorial AIDS Directors, Colorado Department of Public Health & Environment, County of Los Angeles. The program made 68 awards worth $129 million in that time.
